Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care — MEOPanx  

Pain Clinical Trial

Official title: Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care

Status Not yet recruiting

Clinical Trial Summary

The emergency setting, frequently associated with pain and the feeling of loss of control, can cause anxiety in patients.

Reaction anxiety may be an appropriate response to an emergency; Nevertheless, attention must be paid to the evaluation and management of the latter especially as anxiety and pain are closely linked.

Clinical Trial Description

There is a definite interest in the management of patients' pre-hospital anxiety. The literature reports a strong association between anxiety, post-traumatic stress and chronic pain. A study conducted at SAMU 31 also found that anxiety on arrival at the emergency department was a negative factor in the treatment of pain. Anxiety can reduce the pain threshold and promote hyperalgesia.

The management of patient anxiety in pre-hospital offers interesting results in terms of analgesia and satisfaction of users of care and should not be neglected.

MEOPA has recently been available in SMUR vehicles (emergency and resuscitation mobile service) at SAMU 31 (urgent medical assistance service); its availability can lead teams to change their practices. More and more emphasis is placed on the importance of positive communication and comfort for which MEOPA, with its conscious sedating effect, could be a facilitating factor.

The aim of our study is to evaluate the level of anxiety of patients treated by SMUR teams in Toulouse and receiving MEOPA following the usual indications for pain-induced pain or pain alleviation.

This is a pilot study, which focuses on the assessment of anxiety in patients treated in pre-hospital care by SMUR Toulouse and receiving MEOPA as part of their care. No data exists in the literature on this subject.

This descriptive study based on qualitative data collected by the FAS1 scale will provide us with the first data on this population. It does not change the usual management of the patient since only patients who must receive MEOPA following the usual indications for pain relief or pain-induced care will be included in the study ;

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Pain

• NCT number: NCT03613155
• Study type: Observational
• Source: University Hospital, Toulouse
• Contact: Vincent Bounes, MD
• Phone: 05 67 69 16 76
• Email: bounes.v@chu-toulouse.fr
• Status: Not yet recruiting
• Start date: September 2018
• Completion date: September 2019